Inhibition and reversal of the degradation of the antiviral drug (E)-5-(2-bromovinyl)-2'-deoxyuridine in vivo
- 1 February 1985
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 34 (3) , 405-406
- https://doi.org/10.1016/0006-2952(85)90061-9
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Regeneration of the antivirel drug(E)-5-(2-bromovinyl)-2′ -deoxyuridinein vivoNucleic Acids Research, 1984
- Phosphorolysis of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and other 5-substituted-2'-deoxyuridines by purified human thymidine phosphorylase and intact blood plateletsBiochemical Pharmacology, 1983
- Structure-activity relationship of ligands of the pyrimidine nucleoside phosphorylasesBiochemical Pharmacology, 1983
- The human blood platelet: A cellular model to study the degradation of thymidine and its inhibitionBiochemical Pharmacology, 1982
- Inhibition of nucleoside phosphorylase cleavage of 5-fluoro-2'-deoxyuridine by 2,4- pyrimidinedione derivativesBiochemical Pharmacology, 1980
- Pharmacokinetics of E -5-(2-Bromovinyl)-2′-Deoxyuridine in MiceAntimicrobial Agents and Chemotherapy, 1979
- Irreversible enzyme inhibitors. 188. Inhibition of mammalian thymidine phosphorylaseJournal of Medicinal Chemistry, 1971
- Inhibition of thymidine phosphorylase by 6-aminothymine and derivatives of 6-aminouracilBiochemical Pharmacology, 1967